Gutierrez, Marwin http://orcid.org/0000-0002-7995-1110
Rodriguez, Sheila
Soto-Fajardo, Carina http://orcid.org/0000-0001-6148-7789
Santos-Moreno, Pedro http://orcid.org/0000-0001-7802-0317
Sandoval, Hugo http://orcid.org/0000-0002-9622-1558
Bertolazzi, Chiara http://orcid.org/0000-0002-4665-6596
Pineda, Carlos http://orcid.org/0000-0003-0544-7461
Article History
Received: 8 June 2018
Accepted: 5 August 2018
First Online: 11 August 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest regarding this manuscript. M. Gutierrez. Advisory board, scientific consultancies, and consulting fees: AbbVie, Novartis, UCB, Esaote SpA, Janssen, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, Sanofi Aventis. SR, CSF, PSM, HS, CB, CP. No disclosures.